Overview

Combination Therapy for Alcohol Use Disorder

Status:
NOT_YET_RECRUITING

Trial end date:
2028-06-01

Target enrollment:

Participant gender:

Summary

This human laboratory study will collect preliminary safety and efficacy data from a sample of participants enrolled in a 4-week in-patient treatment program for alcohol use disorder.

Phase:

PHASE2

Details

Lead Sponsor:

Johns Hopkins University

Treatments:

Naltrexone